Showing 1 - 10 of 275
market, accounting for about 3/4 full. Regarding the R&D efforts in low-tech sectors, the distance of SMEs to large firms is …
Persistent link: https://www.econbiz.de/10011818829
market, accounting for about 3/4 full. Regarding the R&D efforts in low-tech sectors, the distance of SMEs to large firms is …
Persistent link: https://www.econbiz.de/10011565555
The aim of this paper is to estimate the effect of manufacturing Brazilian firms´ knowledge production on their conditional probability of internationalization. In this way, an empirical study using (i) microdata from World Bank Investment Climate, Brazil 2003 and (ii) nonlinear instrumental...
Persistent link: https://www.econbiz.de/10008461589
Persistent link: https://www.econbiz.de/10011565197
Este artigo procurou traçar um perfil da sociedade brasileira em idade sexualmente ativa com respeito ao conhecimento adquirido sobre HIV/AIDS. Neste sentido procurou-se identificar como fatores socioeconômicos, demográficos, comportamentais e de localização, influenciam no nível de...
Persistent link: https://www.econbiz.de/10008675299
The main aim of this paper is to analyze the probability of busy individuals to have a greater or lesser cost of accessibility in the displacement of their residence to the workplace. The global analysis is based on individual, family and local characteristics. To do so, we assign to the cost of...
Persistent link: https://www.econbiz.de/10008675799
Probit model to check the effects of the introduction of this rule on Brazilian labor market. Our results demonstrate that …
Persistent link: https://www.econbiz.de/10011537882
distributions, in which the dependent variable corresponds to the share of cargo across the available ports for imports and exports …
Persistent link: https://www.econbiz.de/10011372266
Persistent link: https://www.econbiz.de/10010330865
Two major changes in Brazilian legislation during the 1990s reshaped the local pharmaceutical industry: the ratification of the TRIPS agreement including a provision for pipeline inventions in 1996, and a Generic Drug Act in 1999, which introduced bioequivalence tests and facilitated generic...
Persistent link: https://www.econbiz.de/10010330912